Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples